Pharmafile Logo
Pharmafocus logo
Advanced Search
stocks1

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

November 27, 2018
Manufacturing and Production, Research and Development asthma, pharma, trial failure, vectura

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, …

News
nhs_sign

NHS to save £300 million by switching to Humira biosimilars

November 27, 2018
Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma

NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …

News
bmssyracuseny

BMS’ Opdivo+Yervoy combo fails in small cell lung cancer

November 27, 2018
Manufacturing and Production, Research and Development Bristol-Myers Squibb, Cancer, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed that its combo comprising Opdivo (nivolumab) and Yervoy (ipilimumab) failed to meet its primary endpoint as …

News
fda2outsideweb

FDA approves first oral TRK inhibitor with Loxo Oncology’s Vitrakvi

November 27, 2018
Manufacturing and Production, Sales and Marketing Cancer, FDA, Loxo Oncology, Vitrakvi, oncology, pharma

The FDA has announced the approval of the United States’ first-ever oral tyrosine kinase (TRK) inhibitor, Loxo Oncology’s Vitrakvi (larotrectinib), …

News

New Point of Care Testing services from Woodley Equipment Company

November 26, 2018
Business Services Medical Equipment Rental, Point of Care Testing, clinical trials, point-of-care testing

News
Press release
shutterstock_57369385

European Commission approves first and only long-acting opioid dependence therapy

November 26, 2018
Sales and Marketing Europe, opioid crisis, opioids, pharma

Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) …

News
sunpharma

Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk

November 26, 2018
Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma

Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …

News
opioid_crisis

Opioid use disorder market to hit $4.8 billion by 2027, says GlobalData

November 26, 2018
Sales and Marketing US, opioid crisis, opioids, pharma

New findings released by analytics firm GlobalData indicates that the market for opioid use disorder therapies is set to grow …

News
novo_nordisk_flag

Novo Nordisk’s semaglutide meets primary endpoint of reducing cardiovascular events at Phase 3

November 26, 2018
Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide

Novo Nordisk has revealed new Phase 3a data for its investigational GLP-1 analogue therapy semaglutide, showing that the drug met …

News
european_commission_web

Mundipharma’s Neulasta biosimilar approved in EU

November 26, 2018
Sales and Marketing Amgen, EU, Europe, Mundipharma, Neulasta, Pelmeg, pharma

Mundipharma has revealed that Pelmeg, its biosimilar version of Amgen’s Neulasta (pegfilgrastim), has been awarded marketing approval by the European …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kymriah, Mundipharma, UK, US, brexit, pharma, politics, top 10

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the …

News
novartis_window

Novartis’ gene therapy Luxturna becomes first approved European therapy for vision loss subtype

November 23, 2018
Medical Communications, Sales and Marketing EU, Europe, Luxturna, Novartis, pharma, vision loss

Novartis has revealed that its one-time gene therapy Luxturna (voretigene neparvovec) has been awarded approval by the European Commission to …

News

Immuno Biotech owner promoting unlicensed ‘cure’ for cancer, autism and HIV to be sentenced next week

November 23, 2018
Medical Communications Cancer, David Noakes, GcMAF, HIV, UKIP, autism

The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number …

News

New report finds link between social media and poor mental health among young people

November 23, 2018
Medical Communications

Young people between the ages of 11 and 19, living with a mental disorder, were more likely to use social …

News
nhs_andrew_tatlow

NHS hospitals paying 167% more for drugs since 2010/11

November 23, 2018
Medical Communications Cost, NHS, UK, hospitals, pricing

Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …

News

Pfizer’s Daurismo becomes first of its kind to secure FDA approval in acute myeloid leukaemia

November 22, 2018
Research and Development, Sales and Marketing AML, Daurismo, FDA, Pfizer, US, leukaemia

Pfizer has revealed that the FDA has chosen to approve its Daurismo (glasdegib) for the treatment of newly-diagnosed acute myeloid …

News

Cancer Drugs Fund to offer MSD’s Keytruda for lung cancer

November 22, 2018
Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NICE, UK, keytruda, pharma

MSD’s Keytruda (pembrolizumab) will now be made available via the Cancer Drugs Fund for patients in England, as NICE announces …

News
gsk_china_2_2_0_1

GSK retain top spot on access to medicines list

November 22, 2018
Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh

The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …

News

Probiotics have no effect on children with gastroenteritis, study shows

November 22, 2018
Research and Development children, flu, gastroenteritis, probiotics, research

Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …

News

Uninsured patients elibible for no-cost replacement of medicines lost in California wildfires

November 22, 2018
Manufacturing and Production, Sales and Marketing USA, california, insurance, prescription, wildfires

Uninsured citizens in California’s Butte, Los Angeles and Ventura counties will be eligible for a no-cost replacement of medicines lost …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026